Clinical trial

Neuroimaging Study of Bupropion Treatment in Patients With Major Depressive Disorder

NCT01541475

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention Bupropion, Escitalopram Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Escitalopram Normalized identity: escitalopramView linked drug · Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Neuroimaging Study of Bupropion Treatment in Patients With Major Depressive Disorder

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE4

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2009-03-01

PhasePHASE4

Conditions

Major Depressive Disorderverified · MONDO: major depressive disorder

Interventions

Bupropion, EscitalopramDRUG

EscitalopramDRUG · verified · RxNorm: escitalopram

Sponsors & collaborators

Ewha Womans Universitylead sponsor

GlaxoSmithKlinecollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01541475 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.